SOPHARMA AD - Notification of sale of Treasury shares of "Sopharma" AD

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. Current report_65_treasury shares_espi.pdfNotification of sale of Treasury shares of "Sopharma" AD
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 65 / 2024

Date of issue: 2024-06-26

Short name of the issuer

SOPHARMA AD

Subject

Notification of sale of Treasury shares of "Sopharma" AD

Official market - legal basis

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 25, 2024 the Company sold 710 000 (seven hundred and ten thousand) repurchased own shares representing 0.40% of the share capital of the Company, at a total value of BGN 4 217 400,00 on the Bulgarian Stock Exchange, the average price per share was BGN 5,94.

Annexes

File Description

Current report_65_treasury shares_espi.pdfCurrent report_65_treasury shares_espi.pdf Notification of sale of Treasury shares of "Sopharma" AD

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2024-06-26 Ognian Donev Executive director